Loading clinical trials...
Loading clinical trials...
A Phase 2 Pilot Study of KRX-0502 (Ferric Citrate) in Treating Iron-deficiency Anemia in Patients With Stage 3-5 Non-dialysis Dependent Chronic Kidney Disease (NDD-CKD)
Conditions
Interventions
KRX-0502
Locations
3
Israel
Barzilai Medical Center
Ashkelon, Israel
Western Galilee Hospital
Nahariya, Israel
Nazareth Hospital- EMMS
Nazareth, Israel
Start Date
April 1, 2014
Primary Completion Date
November 1, 2014
Completion Date
November 1, 2014
Last Updated
August 24, 2018
NCT05515367
NCT05082584
NCT06352138
NCT06556134
NCT05900635
NCT04667533
Lead Sponsor
Keryx Biopharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions